Logo
homeHome
toggle_offCompany ProfilegroupsBoards & Staffsworkspace_premiumMemberships & PartnersschoolAcademy of Journalismperson_addCareerslinkBlog(EN)emailContact Us
list_altOur JournalslightbulbInstruction for AuthorsbookmarkBrieflands PolicieshandshakePublish My Researchplay_circleJournal Management Systemcredit_cardArticle Processing Chargeszoom_inOpen Peer ReviewimagePublishing Services
menu_bookPublish My Book

Hepatitis Monthly

Official Journal of Research Center for Gastroenterology and Liver Diseases

homeHome
play_circleCurrent Issuecheck_circleAccepted ManuscriptslistAll Issuesformat_indent_increaseIn Press ArticlessearchSearch
helpInstructions
infoJournal InformationgroupsBoards and committeesshareIndexing and Listing Sourcesshow_chartJournal Metricszoom_inOpen Peer Review (OPR)balancePublication Ethics and Malpractice Statementmenu_bookReviewer and AE Registration FormemailSupportphoneContact Us
format_list_bulletedAPC
Authors GuideSubmit Manuscript

Scopus by Title (Ref)

1. Circulating IGF-1 levels and 27 digestive diseases: 461,401 UK biobank prospective analysis

- Yang W. , et al.

2. Somatostatin Effect on Growth Factors in Hepatocellular Carcinoma

- Tsakou A. , et al.

3. Optimizing Nutrition to Counter Sarcopenia in Hepatocellular Carcinoma: A Narrative Review of Mechanisms, Clinical Consequences, and Supportive Therapeutic Options

- Tai H. , et al.

4. Serum Insulin-Like Growth Factor 1 and the Prognosis of Patients With Advanced Liver Diseases: A Meta-Analysis

- Liu Y. , et al.

5. Insulin-like Growth Factor-1 Levels Reflect Muscle and Bone Health and Determine Complications and Mortality in Decompensated Cirrhosis

- Kaur P. , et al.

6. Liver

- Shafqat F. , et al.

7. Sarcopenia in liver cirrhosis: Prevalence, pathophysiology and therapeutic strategies

- Fox R. , et al.

8. Value of IGF-1, RBP, and CHE in the diagnosis of liver cirrhosis

- Duan X.X. , et al.

9. Low Growth Hormone Levels Predict Poor Outcome of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure

- Wu D. , et al.

10. Nutraceuticals for the treatment of sarcopenia in chronic liver disease

- Hey P. , et al.

11. Nutrition in Chronic Liver Disease: Consensus Statement of the Indian National Association for Study of the Liver

- Puri P. , et al.

12. Value of the controlling nutritional status score and psoas muscle thickness per height in predicting prognosis in liver transplantation

- Dai X. , et al.

13. Research advances in hepatocellular carcinoma-related sarcopenia

- Shen S. , et al.

14. Pathogenesis of sarcopenia in liver cirrhosis and current status of its diagnosis and treatment

- Liu J. , et al.

15. Upcoming pharmacological and interventional therapies for the treatment of physical frailty and sarcopenia

- Hey P. , et al.

16. Molecular prognosis in liver cirrhosis

- Athuluri-Divakar S.K. , et al.

17. Factors correlated with serum insulin-like growth factor-I levels in health check-up subjects

- Matsumoto R. , et al.

18. Insulin-like growth factor (IGF) system in liver diseases

- Adamek A. , et al.

19. Sarcopenia in patients with advanced liver disease

- Ponziani F.R. , et al.

20. Molecular prognostic prediction in liver cirrhosis

- Goossens N. , et al.

21. IGF-1 decreases portal vein endotoxin via regulating intestinal tight junctions and plays a role in attenuating portal hypertension of cirrhotic rats

- Zhao T.Y. , et al.

22. Lower levels of insulin-like growth factor-1 standard deviation score are associated with histological severity of non-alcoholic fatty liver disease

- Sumida Y. , et al.

23. Growth hormone/insulin-like growth factor 1 dynamics in adult living donor liver transplantation

- Jara M. , et al.